News

COST funding guaranteed for UK affiliated participants until the end of Horizon 2020

Published on | 5 years ago

Programmes COST COST

As the UK will leave the European Union on 31 January 2020, the COST Association has published the following announcement:

“Whilst the COST Association regrets the UK leaving the European Union, it respects this decision and welcomes the entry into force of the Withdrawal Agreement between the European Union and the UK as of February 1, 2020.

Until the end of Horizon 2020, the current Framework Programme for Research and Innovation, the COST Association will keep funding the UK affiliated participants in all COST activities.

In this context, all measures adopted in 2019 in view of a potential no-deal Brexit are withdrawn.

At this stage, there is no indication on the potential eligibility of UK affiliated participants (including Grant Holders) under Horizon Europe as this will depend on the Free Trade Agreement negotiations between the UK and the EU. The COST Association will therefore attentively follow the developments of Brexit and act in the best interests of the European research and innovation community.”

More information can also be found on the Brexit page of the COST Association.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1641 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.